Barclays’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-3,100
| Closed | -$9K | – | 7509 |
|
|
2017
Q4 | $9K | Sell |
3,100
-4,300
| -58% | -$15.6K | ﹤0.01% | 6545 |
|
|
2017
Q3 | $33K | Buy |
7,400
+6,200
| +517% | +$27.5K | ﹤0.01% | 5570 |
|
|
2017
Q2 | $6K | Sell |
1,200
-8,100
| -87% | -$32.6K | ﹤0.01% | 6211 |
|
|
2017
Q1 | $39K | Sell |
9,300
-66,700
| -88% | -$277K | ﹤0.01% | 5477 |
|
|
2016
Q4 | $314K | Sell |
76,000
-14,700
| -16% | -$78.1K | ﹤0.01% | 3798 |
|
|
2016
Q3 | $735K | Buy |
90,700
+57,700
| +175% | +$491K | ﹤0.01% | 2921 |
|
|
2016
Q2 | $257K | Sell |
33,000
-34,700
| -51% | -$298K | ﹤0.01% | 3741 |
|
|
2016
Q1 | $474K | Buy |
67,700
+19,100
| +39% | +$140K | ﹤0.01% | 3196 |
|
|
2015
Q4 | $486K | Buy |
48,600
+7,500
| +18% | +$68.2K | ﹤0.01% | 3246 |
|
|
2015
Q3 | $247K | Sell |
41,100
-20,300
| -33% | -$165K | ﹤0.01% | 3985 |
|
|
2015
Q2 | $491K | Sell |
61,400
-40,900
| -40% | -$387K | ﹤0.01% | 3489 |
|
|
2015
Q1 | $921K | Sell |
102,300
-79,100
| -44% | -$988K | ﹤0.01% | 3062 |
|
|
2014
Q4 | $2.18M | Sell |
181,400
-24,100
| -12% | -$294K | ﹤0.01% | 2454 |
|
|
2014
Q3 | $1.85M | Buy |
205,500
+147,000
| +251% | +$1.36M | ﹤0.01% | 2736 |
|
|
2014
Q2 | $410K | Buy |
58,500
+23,600
| +68% | +$94.2K | ﹤0.01% | 4169 |
|
|
2014
Q1 | $105K | Sell |
34,900
-52,300
| -60% | -$183K | ﹤0.01% | 5411 |
|
|
2013
Q4 | $262K | Buy |
87,200
+15,000
| +21% | +$43.5K | ﹤0.01% | 4744 |
|
|
2013
Q3 | $217K | Buy |
72,200
+25,500
| +55% | +$175K | ﹤0.01% | 4964 |
|
|
2013
Q2 | $382K | Buy |
+46,700
| New | +$357K | ﹤0.01% | 4529 |
|